Patents by Inventor Inger Nordén

Inger Nordén has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulation
    Patent number: 7338667
    Abstract: The present invention concerns an extended release formulation having an accelerating erosion and/or dissolution rate of the surface of the formulation. The formulation comprises a drug having low solubility in water dispersed or dissolved in at least one erasable hydrophilic polymeric matrix.
    Type: Grant
    Filed: January 15, 2003
    Date of Patent: March 4, 2008
    Assignee: Watson Pharmaceuticals, Inc.
    Inventors: Inger Nordén, Catarina Carling, Peter Fyhr
  • Pharmaceutical formulation
    Publication number: 20030108606
    Abstract: The present invention concerns an extended release formulation having an accelerating erosion and/or dissolution rate of the surface of the formulation. The formulation comprises a drug having low solubility in water dispersed or dissolved in at least one erodable hydrophilic polymeric matrix.
    Type: Application
    Filed: January 15, 2003
    Publication date: June 12, 2003
    Applicant: AMARIN DEVELOPMENT AB
    Inventors: Inger Norden, Catarina Carling, Peter Fyhr
  • Pharmaceutical formulation
    Publication number: 20020114831
    Abstract: The present invention concerns an extended release formulation having an accelerating erosion and/or dissolution rate of the surface of the formulation. The formulation comprises a drug having low solubility in water dispersed or dissolved in at least one erodable hydrophilic polymeric matrix.
    Type: Application
    Filed: February 21, 2001
    Publication date: August 22, 2002
    Inventors: Inger Norden, Catarina Carling, Peter Fyhr